Nanodiamond delivery circumvents tumor resistance to doxorubicin

Acta Pharmacol Sin. 2011 May;32(5):543-4. doi: 10.1038/aps.2011.58. Epub 2011 May 2.
No abstract available

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / administration & dosage*
  • Antibiotics, Antineoplastic / pharmacology
  • Doxorubicin / administration & dosage*
  • Doxorubicin / pharmacology
  • Drug Delivery Systems
  • Drug Resistance, Neoplasm
  • Humans
  • Nanodiamonds*
  • Neoplasms / drug therapy
  • Neoplasms / pathology

Substances

  • Antibiotics, Antineoplastic
  • Nanodiamonds
  • Doxorubicin